Home Compare BOL.PA vs PFE
Stock Comparison · Structural lead, mixed market

Bolloré vs Pfizer: Which Stock Looks Stronger in 2026?

Pfizer holds the cleaner structural position, with the lead spread across growth and valuation. Bolloré SE still has the edge on stability, which keeps the comparison from looking entirely one-sided. The market setup is currently leaning toward Bolloré SE, which does not confirm the structural lead. That leaves a split case: the structural lead stays with Pfizer, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (BOL.PA: STOXX 600, PFE: S&P 500).

Updated 2026-07-05

Most of the visible separation comes from growth. Pfizer Inc. leads by 15 points on the overall comparison score.

Trajectory Similarity
0.57
Moderately similar
Peer-set rank: #11
within Bolloré SE's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The strongest overlap appears in investment intensity and recent revenue growth.

Similarity drivers
investment intensityrecent revenue growth
What reduces the match
revenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BOL.PA
Bolloré SE
32
Peer-Score
Signal qualitylow
Peer basis: STOXX 600
vs
PFE
Pfizer Inc.
47
Peer-Score
Signal qualityHigh
Peer basis: S&P 500

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: BOL.PA vs PFE Profitability 10 16 Stability 76 49 Valuation 46 83 Growth 0 38 BOL.PA PFE
Gap Ranking
#1 Growth +38
#2 Valuation +37
#3 Stability +27
#4 Profitability +6
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BOL.PA and PFE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BOL.PAPFE Relative valuation Structural strength

Structure stays fairly close here, while current pricing still looks more supportive for Pfizer Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where BOL.PA and PFE each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY BOL.PA Elevated · above norm 0th 50th 100th 59 pct gap PFE Lower · near norm 0th 50th 100th 87th 28th
Today PFE sits in the lower-middle of its own 5-year history (28th percentile), while BOL.PA sits higher in its own history (87th). Within each stock's own 5-year context, PFE is at a historically more favourable entry position than BOL.PA. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Growth
Neither side looks especially strong on growth, though Pfizer Inc. still ranks somewhat higher.
Valuation
Both rank well on valuation, but Pfizer Inc. still holds a clear edge.
Growth — Dominant Gap
BOL.PA
0
PFE
38
Gap+38in favour of PFE

One company is still expanding while the other is contracting, which creates a very wide growth split.

What keeps the gap from being one-sided

Stability still leans toward Bolloré SE, so the lead is real without reading as one-way.

What this means for the comparison

The lead is built on both growth and valuation — though stability still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the BOL.PA vs PFE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how BOL.PA and PFE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.